<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://harvardscience.harvard.edu" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>all depression stories</title>
 <link>http://harvardscience.harvard.edu/topic/4113</link>
 <description>Stories within a topic (RSS)</description>
 <language>en</language>
<item>
 <title>Researchers look at antidepressants and risk of suicide among kids</title>
 <link>http://harvardscience.harvard.edu/medicine-health/articles/researchers-look-antidepressants-and-risk-suicide-among-kids</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;Which is more likely to push a depressed child to suicide: not taking antidepressant drugs or taking antidepressant drugs?&lt;/p&gt;&lt;p&gt;Medical experts have struggled with this question at least since 1990 when Harvard researchers reported that six people developed suicidal feelings soon after taking Prozac (fluoxetine). This was the first of the now widely prescribed serotonin drugs to ease depression. Called selective serotonin reuptake inhibitors, or SSRIs, such medications ease the problems of depression, anxiety, and obsessive-compulsive behavior by decreasing the activity of a brain chemical known to affect moods.&lt;/p&gt;&lt;p&gt;&lt;a href=&quot;http://harvardscience.harvard.edu/medicine-health/articles/researchers-look-antidepressants-and-risk-suicide-among-kids&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Tue, 02 Oct 2007 09:38:16 -0400</pubDate>
 <dc:creator>50443248</dc:creator>
 <guid isPermaLink="false">7477 at http://harvardscience.harvard.edu</guid>
</item>
<item>
 <title>Panel offers valuable advice on coping with stress and depression</title>
 <link>http://harvardscience.harvard.edu/medicine-health/articles/panel-offers-valuable-advice-coping-with-stress-and-depression</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;A full house was on hand for Wednesday’s (May 2) panel discussion on coping with stress, a “Caring for the Harvard Community” event. Facilitated by Families for Depression Awareness — a nonprofit organization founded by speaker Julie Totten after her brother committed suicide in 1999 — the talk focused on stress and its relationship to depression.&lt;/p&gt;&lt;p&gt;Paul Barreira, a psychiatrist and the director of Harvard’s Department of Behavioral Health and Academic Counseling, started the meeting by presenting some disturbing statistics, including that 60 percent of students consistently report feeling “overwhelmed” and up to 14 percent are diagnosed with depression — though nearly double that number believe their depression has reached clinical levels.&lt;/p&gt;&lt;p&gt;&lt;a href=&quot;http://harvardscience.harvard.edu/medicine-health/articles/panel-offers-valuable-advice-coping-with-stress-and-depression&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Tue, 02 Oct 2007 12:14:29 -0400</pubDate>
 <dc:creator>50443248</dc:creator>
 <guid isPermaLink="false">7492 at http://harvardscience.harvard.edu</guid>
</item>
<item>
 <title>Verbal beatings hurt as much as sexual abuse</title>
 <link>http://harvardscience.harvard.edu/culture-society/articles/verbal-beatings-hurt-much-sexual-abuse</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;Sticks and stones may break my bones,&lt;/p&gt;&lt;p&gt;But names will never hurt me. …&lt;/p&gt;&lt;p&gt;That often repeated children’s rhyme is wrong, according to Harvard University psychiatrists. Scolding, swearing, yelling, blaming, insulting, threatening, ridiculing, demeaning, and criticizing can be as harmful as physical abuse, sexual abuse outside the home, or witnessing physical abuse at home, notes a report in the April issue of the Harvard Mental Health Letter.&lt;/p&gt;</description>
 <pubDate>Tue, 02 Oct 2007 13:37:29 -0400</pubDate>
 <dc:creator>50443248</dc:creator>
 <guid isPermaLink="false">7501 at http://harvardscience.harvard.edu</guid>
</item>
<item>
 <title>Depression is bad for the heart</title>
 <link>http://harvardscience.harvard.edu/medicine-health/articles/depression-bad-heart</link>
 <description>&lt;!--paging_filter--&gt;Depression is more likely to break your heart than smoking or  eating fatty food.&lt;p&gt;&quot;Recurrence of cardiovascular events, including heart attacks,  strokes, cardiac arrest, severe chest pain and other problems is  more closely linked to depression than to high cholesterol,  smoking, high blood pressure, or diabetes,&quot; according to a  Harvard Medical School publication.&lt;p&gt;An article printed in the February 2006 issue of Harvard Mental  Health Letter points out that patients who are depressed at the  time of hospitalization for heart conditions &quot;are two to four  times more likely than average to die or to suffer further  cardiovascular events during the following year.&quot;&lt;p&gt;And, just as sad, &quot;about 50 percent of patients hospitalized with  coronary heart disease have some depressive symptoms, and up  to 20 percent develop major depression.&quot;&lt;p&gt;Depressed people who also are anxious add to their problems.  According to one recent study, whereas depression doubles the  risk of heart problems recurring, anxiety triples that risk.&lt;p&gt;It&#039;s not unusual for depressed people to suffer from anxiety. The  two go together like pretzels and beer, so well that scientists  have given it a new name - the Type D (for distressed)  personality. Such people are chronically gloomy, worried,  pessimistic, and lack self-assurance. The Harvard article  mentions research in Belgium that found that &quot;over a 10-year- period, patients in a cardiac rehabilitation program were three  times as likely to die or have a second heart attack if they had  this kind of personality.&quot;&lt;p&gt;Why does this happen? The Harvard publication notes that your  mind and mood can push you into a chronic state of emergency  readiness. Such people are ready to fight or run even when  there&#039;s nothing to fight about or run from. In real emergencies,  stress hormones rise, blood vessels constrict, your heart speeds  up, appetite slackens, and it&#039;s harder to fall asleep. Inflammatory  chemicals increase in the blood, which becomes stickier in  anticipation of wounds that will need healing. When the scare  ends, this red alert shuts down - unless you are seriously  depressed or anxious.&lt;p&gt;Then, stress hormones stay jacked up. Inflammation may  damage the lining of your arteries. Blood vessels become less  flexible. The heart responds more sluggishly to internal signals  telling it to slow down as the body&#039;s demands change.&lt;p&gt;It&#039;s hard to figure out exactly what happens. As the article notes,  &quot;cause and effect are difficult to disentangle in the relationship  between depression and heart disease.&quot; Vicious cycles arise.  Depression damages the heart and blood vessels, and that  causes further depression.</description>
 <pubDate>Mon, 26 Mar 2007 06:25:04 -0400</pubDate>
 <dc:creator>70652986</dc:creator>
 <guid isPermaLink="false">3763 at http://harvardscience.harvard.edu</guid>
</item>
<item>
 <title>Depression linked to previously unknown dopamine regulator</title>
 <link>http://harvardscience.harvard.edu/medicine-health/articles/depression-linked-previously-unknown-dopamine-regulator</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;Li-Huei Tsai, Harvard Medical School (HMS) professor of  pathology, HMS research fellow Sang Ki Park, and colleagues  worked with mice and found a novel function for the molecule  Par-4 (prostate apoptosis response 4) as a binding partner for  dopamine receptor D2. When mice deficient in Par-4 were  subjected to stress, they showed depression-like behaviors,  proposing Par-4-as a molecular link between dopamine  signaling and depression. Par-4 was previously implicated as a  proapoptotic factor in neurodegenerative diseases such as  Alzheimer&#039;s disease. These new findings reveal an unexpected  role for Par-4 in the dopamine system and present a rare  glimpse of molecular mechanisms behind clinical depression.
&lt;p&gt;Although the cause of depression is multifaceted, a hypothesis  based on deficiency or imbalance of serotonin and/or  noradrenaline as the root of depression has been a central topic  of research. Drugs that currently treat depression have  significant delays before becoming effective, and many people  are resistant to the current therapies.
&lt;p&gt;The brain&#039;s mood, reward, and motivation circuits are mainly  governed by dopamine and have been regarded as potential  targets for treating depression. Many of these functions are  integrated by the medium spiny neurons of the striatum, which  respond to dopamine. Dopamine exerts its function in target  cells through five known subtypes of dopamine receptors.  Impairment in the function of dopamine D2 receptor is  implicated in various neuropsychiatric disorders.&lt;/p&gt;
</description>
 <pubDate>Mon, 26 Mar 2007 06:21:43 -0400</pubDate>
 <dc:creator>70652986</dc:creator>
 <guid isPermaLink="false">3684 at http://harvardscience.harvard.edu</guid>
</item>
<item>
 <title>Food ingredients may be as effective as antidepressants</title>
 <link>http://harvardscience.harvard.edu/medicine-health/articles/food-ingredients-may-be-effective-antidepressants</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;Researchers report that omega-3 fatty acids and uridine, two  substances in foods such as fish, walnuts, molasses, and sugar  beets, prevented depression in rats as effectively as  antidepressant drugs.
&lt;p&gt;&quot;Giving rats a combination of uridine and omega-3 fatty acids  produced immediate effects that were indistinguishable from  those caused by giving the rats standard antidepressant  medications,&quot; explains lead author of the study William  Carlezon, PhD, director of McLean&#039;s Behavioral Genetics  Laboratory.
&lt;p&gt;Researchers examined how omega-3 fatty acids and uridine  affected rats exposed to stress and found that rats given  injections of or fed diets containing the nutrients showed less  despair than untreated rats.
&lt;p&gt;While uridine worked immediately, the effects of omega-3 fatty  acids took longer to develop, and shorter treatments of omega -3 fatty acids alone did not relieve depression in the rats.  Benefits emerged more quickly when the rats were given the  nutrients together.
&lt;p&gt;&quot;Omega-3 fatty acids may make the mitochondrial membranes  more flexible and uridine may provide raw material to make  chemical reactions occur more readily,&quot; adds co-author Perry  Renshaw, MD, PhD, director of McLean&#039;s Brain Imaging Center.
&lt;p&gt;&quot;This work provides more evidence that our behavior can have  a tremendous influence on how we feel and act,&quot; says Carlezon.&lt;/p&gt;
</description>
 <pubDate>Mon, 26 Mar 2007 06:18:55 -0400</pubDate>
 <dc:creator>70652986</dc:creator>
 <guid isPermaLink="false">3633 at http://harvardscience.harvard.edu</guid>
</item>
<item>
 <title>Ritalin use in childhood may increase depression</title>
 <link>http://harvardscience.harvard.edu/medicine-health/articles/ritalin-use-childhood-may-increase-depression</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;A study, led by McLean Hospital&#039;s William Carlezon and Susan Andersen, found that adult rats given Ritalin as juveniles behaved differently than their placebo-treated counterparts in a host of tests that reflect mood and attention.&amp;#160; Published in the Dec. 15, 2003 issue of Biological Psychiatry, the study follows up previous work by the researchers showing that young rats given Ritalin were less likely to find cocaine pleasurable as adults.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://harvardscience.harvard.edu/medicine-health/articles/ritalin-use-childhood-may-increase-depression&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Mon, 26 Mar 2007 05:34:33 -0400</pubDate>
 <dc:creator>70652986</dc:creator>
 <guid isPermaLink="false">3480 at http://harvardscience.harvard.edu</guid>
</item>
<item>
 <title>Millions of Americans suffer from major depression</title>
 <link>http://harvardscience.harvard.edu/culture-society/articles/millions-americans-suffer-major-depression</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;A Harvard Medical School study found high rates of  depression throughout the U.S. population. The researchers  analyzed the depression of over 9,000 Americans and evaluated  depression&#039;s effect on daily activities and treatment received, if  any.
&lt;p&gt;Critics have theorized that depression has been reported as  more widespread than it really is, said survey leader Ronald  Kessler, HMS professor of health care policy. &quot;But we found  that the majority of people with depression are severe cases,  and only a small minority are mild cases.&quot;
&lt;p&gt;The inadequate treatment received by 80 percent of those who  were treated sprang from inappropriate dosing of  antidepressants by physicians, patient discontinuation of  treatment, and the use of unproven treatments. &quot;Emphasis on  screening and expansion of treatment needs to be accompanied  by a parallel emphasis on treatment quality improvement,&quot;  Kessler&#039;s team writes.
&lt;p&gt;The study found that women and people previously married  were most at risk for major depression over a lifetime; in a 12- month period, depression was more common among  homemakers, people never married, and those who had not  completed high school or who were living in poverty.
&lt;p&gt;The researchers found depression affects roughly 6.6 percent of  American adults in a given year, and 16.2 percent of American  adults in a lifetime.&lt;/p&gt;
</description>
 <pubDate>Mon, 26 Mar 2007 06:18:59 -0400</pubDate>
 <dc:creator>70652986</dc:creator>
 <guid isPermaLink="false">3635 at http://harvardscience.harvard.edu</guid>
</item>
<item>
 <title>Testosterone drives away the blues</title>
 <link>http://harvardscience.harvard.edu/medicine-health/articles/testosterone-drives-away-blues</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;In the 1940s, experiments showed that major depression can be relieved by injecting testosterone into men with low levels of that hormone. The treatment never caught on because the shots are painful, and effective antidepressant drugs started coming to market. More recently, however, testosterone patches and gels became available. In June 2000, the United States Food and Drug Administration approved a new form of gel for treating muscle loss, decreased sex drive, lack of energy, and other symptoms of so-called hypogonadism, or underactivity of the testes. Harrison Pope, a Harvard professor of psychiatry, wondered if the gel might also help males with the combination of low testosterone and depression not treated successfully with drugs.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://harvardscience.harvard.edu/medicine-health/articles/testosterone-drives-away-blues&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Mon, 26 Mar 2007 05:26:43 -0400</pubDate>
 <dc:creator>70652986</dc:creator>
 <guid isPermaLink="false">3302 at http://harvardscience.harvard.edu</guid>
</item>
<item>
 <title>Patching up depression</title>
 <link>http://harvardscience.harvard.edu/medicine-health/articles/patching-depression</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;In a study, almost half of the people who wore an antidepressant skin patch recovered after only six weeks, and many of them &quot;showed remarkable improvement much sooner,&quot; according to researcher Alexander Bodkin. &quot;The patch worked, and worked rapidly without toxic side effects. The potential is very exciting.&quot; Bodkin and his colleagues, working at six medical centers, completed the first tests of the patch in 1998. The centers included Harvard-affiliated McLean Hospital in Belmont, where Bodkin did his research. These tests involved 177 people; 89 of them wore patches with an antidepression drug and 87 wore placebo patches with no drug. Six weeks later, 42 percent of those who wore the active patch (37 people), no longer felt the pangs of depression.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://harvardscience.harvard.edu/medicine-health/articles/patching-depression&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Mon, 26 Mar 2007 05:25:47 -0400</pubDate>
 <dc:creator>70652986</dc:creator>
 <guid isPermaLink="false">3278 at http://harvardscience.harvard.edu</guid>
</item>
<item>
 <title>Researchers identify genes that trigger depression</title>
 <link>http://harvardscience.harvard.edu/medicine-health/articles/researchers-identify-genes-trigger-depression</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;A substance known as CREB controls gene expression in the brain. It also appears to be active in mood disorders. A group of Harvard researchers at McLean Hospital in Belmont, Mass., have developed methods that allowed them to selectively activate or deactivate CREB in the brains of rats. They found that activation of CREB in frontal portions of the brain caused signs of depression that normally occur only in response to stressful situations. The findings were published in the September 2001 issue of The Journal of Neuroscience. &quot;Stress causes many changes in the brain,&quot; said William Carlezon, director of McLean&#039;s Behavioral Genetics Laboratory and an assistant professor of psychiatry at Harvard Medical School. &quot;We have identified CREB as a critical element in a chemical pathway that, when activated, can cause certain symptoms of depression.&quot; Carlezon&#039;s group also found that blocking CREB lessened the effects of stress, and made rats behave as if they were being treated with antidepressant drugs.&lt;/p&gt;
</description>
 <pubDate>Mon, 26 Mar 2007 05:16:21 -0400</pubDate>
 <dc:creator>70652986</dc:creator>
 <guid isPermaLink="false">3054 at http://harvardscience.harvard.edu</guid>
</item>
<item>
 <title>High levels of depression, post-traumatic stress disorder remain in Bosnian refugees</title>
 <link>http://harvardscience.harvard.edu/medicine-health/articles/high-levels-depression-post-traumatic-stress-disorder-remain-bosnian-refuge</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;In 1996, Harvard Medical School researchers began following the mental health impact of the Bosnian war on individuals in a refugee camp in Croatia. Most of the refugees have now returned to Bosnia, though some have resettled elsewhere. A recently released report presents the findings of the first longitudinal study to focus on refugees who remain in the conflict region. Researchers found that the refugees continue to exhibit high levels of mental illnesses such as depression and posttraumatic stress disorder. &quot;We found that people who face mass violence or torture cannot be expected to snap back to good mental health on their own,&quot; says Richard Mollica, Harvard Medical School associate professor of psychiatry and director of the Harvard Program in Refugee Trauma. &quot;This study reveals the importance of incorporating long-term mental health initiatives into recovery efforts, especially for the elderly and disabled who appear at greater risk of mortality.&quot; The study was supported by a grant from the National Institutes of Mental Health.&lt;/p&gt;
</description>
 <pubDate>Mon, 26 Mar 2007 05:14:41 -0400</pubDate>
 <dc:creator>70652986</dc:creator>
 <guid isPermaLink="false">3013 at http://harvardscience.harvard.edu</guid>
</item>
<item>
 <title>Eighty-five percent of immigrant children separated from families during migration</title>
 <link>http://harvardscience.harvard.edu/culture-society/articles/eighty-five-percent-immigrant-children-separated-families-during-migration</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;An ongoing study of more than 400 children who have immigrated to the United States shows that 85 percent of them experience separation from one or both parents during the process of moving to this country. About 35 percent of these children are separated from their fathers for more than five years. Nearly half (49 percent) of these children have been separated from both parents at some time during the moving process. Carola Su&amp;#225;rez-Orozco, Irina Todorova, and Josephine Louie, researchers from the Harvard Immigration Project at the Harvard Graduate School of Education, said the findings are significant for two reasons: immigrant children who are separated from their parents show more symptoms of depression than those who remain with their families, and 20 percent of children in the United States are now growing up in immigrant homes.&lt;/p&gt;
</description>
 <pubDate>Mon, 26 Mar 2007 05:12:58 -0400</pubDate>
 <dc:creator>70652986</dc:creator>
 <guid isPermaLink="false">2970 at http://harvardscience.harvard.edu</guid>
</item>
<item>
 <title>Children from working-class families twice as likely to be depressed adults</title>
 <link>http://harvardscience.harvard.edu/culture-society/articles/children-working-class-families-twice-likely-be-depressed-adults</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;Children from low socioeconomic backgrounds have an elevated risk of depression throughout their lifetimes, even if they become more professionally successful than their parents. That&#039;s the conclusion of a study conducted by Harvard School of Public Health researcher Stephen Gilman and colleagues. The study also suggests that girls raised in working-class households are more likely to develop depression as adults than boys in similar households. Gilman points out that the majority of participants in the study did not develop depression, indicating that childhood factors are only part of the story of major depression.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://harvardscience.harvard.edu/culture-society/articles/children-working-class-families-twice-likely-be-depressed-adults&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Mon, 26 Mar 2007 05:13:02 -0400</pubDate>
 <dc:creator>70652986</dc:creator>
 <guid isPermaLink="false">2972 at http://harvardscience.harvard.edu</guid>
</item>
<item>
 <title>Electromagnets used in treating depression</title>
 <link>http://harvardscience.harvard.edu/medicine-health/articles/electromagnets-used-treating-depression</link>
 <description>&lt;!--paging_filter--&gt;&lt;p&gt;Recent studies by Harvard researchers at McLean Hospital in Belmont, Mass., have enlarged the body of knowledge about a promising, though still experimental, treatment for a variety of psychiatric disorders. The treatment is called &quot;transcranial magnetic stimulation,&quot; and essentially involves placing a powerful electromagnet on a person&#039;s scalp. The electromagnet alters brain activity by inducing an electromagnetic current in the underlying cortical neurons. Researchers aren&#039;t sure why that would have a therapeutic effect.&lt;/p&gt;
&lt;p&gt;&lt;a href=&quot;http://harvardscience.harvard.edu/medicine-health/articles/electromagnets-used-treating-depression&quot;&gt;read more&lt;/a&gt;&lt;/p&gt;</description>
 <pubDate>Mon, 26 Mar 2007 05:14:14 -0400</pubDate>
 <dc:creator>70652986</dc:creator>
 <guid isPermaLink="false">3002 at http://harvardscience.harvard.edu</guid>
</item>
</channel>
</rss>
